{ "aliases": [ "2'-Fucosyllactose", "2'-Fucosyllactose, Powder", "2-Fucosyllactose" ], "also_carried_by": [], "also_carried_total": 0, "also_printed": [], "axis3": { "reason": "not_a_measurement_product", "status": "undefined" }, "baseline_route": true, "brand_mix": {}, "brand_mix_of": 0, "carried_by": [], "carrier_count": 0, "cfu_spread": null, "claims": [ { "checked_at": "2026-09-20T00:00:00Z", "claim_id": "claim:s--hmo:entity.prevalence", "denominator": 13330, "denominator_status": "ok", "denominator_unit": "observed label versions", "entity_id": "gut_substance:hmo", "number": 3, "page_id": "s--hmo", "provenance": "organism_rows.csv; label_versions.csv", "query": "entity containing labels; competition rank by distinct label count within entity type", "query_commit": "90a5050d2327baae3d738638237b48fb29cb01b0", "query_id": "entity.prevalence", "query_links": [], "rows_after_dedupe": 3, "rows_before_dedupe": 13330, "rule_id": "entity.prevalence", "sentence": "HMO appears on 3 of 13,330 labels in the NIH DSLD snapshot (Sep 2026), from 2 brands; rank 11 of 11 substances by distinct label count.", "snapshot_hash": "b7633f732437b71d37c215a03b19abfa8c91d45411579d976d6a926a0140339a", "status": "ok", "template_id": "entity.prevalence", "values_json": "{\"brands\": 2, \"denominator\": 13330, \"labels\": \"labels in the NIH DSLD snapshot (Sep 2026)\", \"name\": \"HMO\", \"number\": 3, \"rank\": 11, \"rank_text\": \"rank 11 of 11 substances\", \"rank_total\": 11, \"rank_unit\": \"substances\", \"share\": \"0.0%\", \"window\": \"NIH DSLD snapshot Sep 2026\"}", "window": "NIH DSLD snapshot Sep 2026" }, { "checked_at": "2026-09-20T00:00:00Z", "claim_id": "claim:s--hmo:entity.grams", "denominator": 3, "denominator_status": "ok", "denominator_unit": "containing labels", "entity_id": "gut_substance:hmo", "number": 0, "page_id": "s--hmo", "provenance": "entity label_versions; detailed ingredientRows", "query": "matching active detailed ingredientRows including nestedRows with gram units; no blend allocation", "query_commit": "90a5050d2327baae3d738638237b48fb29cb01b0", "query_id": "entity.grams", "query_links": [], "rows_after_dedupe": 0, "rows_before_dedupe": 3, "rule_id": "entity.grams", "sentence": "0 of 3 containing labels in the NIH DSLD snapshot (Sep 2026) print grams per serving for HMO (0.0%); 3 light records have quantities unavailable.", "snapshot_hash": "b7633f732437b71d37c215a03b19abfa8c91d45411579d976d6a926a0140339a", "status": "ok", "template_id": "entity.grams", "values_json": "{\"denominator\": 3, \"labels\": \"labels in the NIH DSLD snapshot (Sep 2026)\", \"light\": 3, \"name\": \"HMO\", \"number\": 0, \"share\": \"0.0%\", \"window\": \"NIH DSLD snapshot Sep 2026\"}", "window": "NIH DSLD snapshot Sep 2026" }, { "checked_at": "2026-09-20T00:00:00Z", "claim_id": "claim:s--hmo:entity.evidence", "denominator": 39, "denominator_status": "ok", "denominator_unit": "loaded PMID records", "entity_id": "gut_substance:hmo", "number": 39, "page_id": "s--hmo", "provenance": "evidence_ledger.csv", "query": "evidence_ledger: selected source, query status, PubMed count and loaded records", "query_commit": "90a5050d2327baae3d738638237b48fb29cb01b0", "query_id": "entity.evidence", "query_links": [ { "label": "Published PubMed query", "url": "https://pubmed.ncbi.nlm.nih.gov/?term=%28%28%28%222%27-FL%22%5Bti%5D%20OR%20%222-fucosyllactose%22%5Bti%5D%20OR%20%22human%20milk%20oligosaccharides%22%5Btiab%5D%29%29%29%20AND%20randomized%20controlled%20trial%5Bpt%5D%20AND%20humans%5Bmh%5D%20NOT%20%28retracted%20publication%5Bpt%5D%20OR%20retraction%20of%20publication%5Bpt%5D%29" } ], "rows_after_dedupe": 39, "rows_before_dedupe": 39, "rule_id": "entity.evidence", "sentence": "39 PubMed records indexed as human randomized controlled trials match the published query (as of 2026-09-15). 39 records (retracted records excluded; 0 retracted records match the query separately).", "snapshot_hash": "b7633f732437b71d37c215a03b19abfa8c91d45411579d976d6a926a0140339a", "status": "ok", "template_id": "entity.evidence", "values_json": "{\"denominator\": 39, \"evidence_text\": \"39 PubMed records indexed as human randomized controlled trials match the published query (as of 2026-09-15). 39 records (retracted records excluded; 0 retracted records match the query separately).\", \"labels\": \"labels in the NIH DSLD snapshot (Sep 2026)\", \"name\": \"HMO\", \"number\": 39, \"share\": \"100.0%\", \"window\": \"NIH DSLD snapshot Sep 2026\"}", "window": "NIH DSLD snapshot Sep 2026" }, { "checked_at": "2026-09-20T00:00:00Z", "claim_id": "claim:s--hmo:entity.registered_trials", "denominator": null, "denominator_status": "undefined", "denominator_unit": "interventional registry studies", "entity_id": "gut_substance:hmo", "number": 60, "page_id": "s--hmo", "provenance": "evidence_ledger.csv", "query": "evidence_ledger: ClinicalTrials.gov ok and valid interventional count", "query_commit": "90a5050d2327baae3d738638237b48fb29cb01b0", "query_id": "entity.registered_trials", "query_links": [ { "label": "Published ClinicalTrials.gov query", "url": "https://clinicaltrials.gov/search?query=%222%27-FL%22%20OR%20%222-fucosyllactose%22%20OR%20%22human%20milk%20oligosaccharides%22" } ], "rows_after_dedupe": 60, "rows_before_dedupe": null, "rule_id": "entity.registered_trials", "sentence": "60 interventional studies on ClinicalTrials.gov match the published query.", "snapshot_hash": "b7633f732437b71d37c215a03b19abfa8c91d45411579d976d6a926a0140339a", "status": "ok", "template_id": "entity.registered_trials", "values_json": "{\"denominator\": null, \"labels\": \"labels in the NIH DSLD snapshot (Sep 2026)\", \"name\": \"HMO\", \"number\": 60, \"registered_text\": \"60 interventional studies on ClinicalTrials.gov match the published query.\", \"share\": \"undefined: no observations\", \"window\": \"NIH DSLD snapshot Sep 2026\"}", "window": "NIH DSLD snapshot Sep 2026" }, { "checked_at": "2026-09-20T00:00:00Z", "claim_id": "claim:s--hmo:entity.price", "denominator": 3, "denominator_status": "ok", "denominator_unit": "containing SKUs", "entity_id": "gut_substance:hmo", "number": 0, "page_id": "s--hmo", "provenance": "prices.csv; label_versions.csv", "query": "distinct containing sku IDs with numeric prices; no inference from undefined price rows", "query_commit": "90a5050d2327baae3d738638237b48fb29cb01b0", "query_id": "entity.price", "query_links": [], "rows_after_dedupe": 0, "rows_before_dedupe": 3, "rule_id": "entity.price", "sentence": "0 of 3 SKUs containing HMO have a numeric price observation (0.0%) in the release accompanying the NIH DSLD snapshot Sep 2026.", "snapshot_hash": "b7633f732437b71d37c215a03b19abfa8c91d45411579d976d6a926a0140339a", "status": "ok", "template_id": "entity.price", "values_json": "{\"denominator\": 3, \"labels\": \"labels in the NIH DSLD snapshot (Sep 2026)\", \"name\": \"HMO\", \"number\": 0, \"share\": \"0.0%\", \"window\": \"NIH DSLD snapshot Sep 2026\"}", "window": "NIH DSLD snapshot Sep 2026" } ], "cohort_manifest_sha256": "3a8805d95e34cbd3ccdc36613e5bbcd4a75c17b7e07e420b65aa54f786a13400", "compared_with": [], "designation_rank_counts": [ 242, 12, 574, 411, 464, 21, 31, 3, 31, 5, 6 ], "dose_spread": null, "eligibility": { "label_count": 3, "on_market_label_count": 3, "on_market_sku_count": 3, "type": "gut_substance" }, "entity": { "brand_id": "", "canonical_name": "HMO", "cohort_id": "", "entity_id": "gut_substance:hmo", "taxonomy_policy_json": "{}", "type": "gut_substance" }, "entity_id": "gut_substance:hmo", "evidence": { "aggregate_key": "", "as_of": "2026-09-15", "conditions_json": "[]", "ctgov_error": "", "ctgov_interventional_count": 60, "ctgov_query": "\"2'-FL\" OR \"2-fucosyllactose\" OR \"human milk oligosaccharides\"", "ctgov_query_valid": true, "ctgov_retrieved_at": "2026-09-15T18:43:05Z", "ctgov_status": "ok", "direction": "", "direction_balance": "", "dose_unit": "", "entity_id": "gut_substance:hmo", "evidence_amount": 1, "evidence_member_id": "gut_substance:hmo", "evidence_source": "v2", "matched_records_json": "[{\"pmid\": \"42635599\", \"title\": \"2'-Fucosyllactose modulates gut microbiota and systemic metabolism in mild-to-moderate ulcerative colitis: a randomized crossover trial.\", \"year\": \"2026\"}, {\"pmid\": \"42588060\", \"title\": \"2'-Fucosyllactose Effects on Preterm Growth, Tolerance, and Neurobehavior: A Double-Blind, Randomized, Placebo-Controlled Pilot.\", \"year\": \"2026\"}, {\"pmid\": \"41865803\", \"title\": \"Vitamin D and its role in human milk oligosaccharide production.\", \"year\": \"2026\"}, {\"pmid\": \"41243448\", \"title\": \"2'-Fucosyllactose supplementation results in a transient improvement in gut microbial resilience after vancomycin use in adults with overweight or obesity: a randomized, double-blind, placebo-controlled intervention.\", \"year\": \"2025\"}, {\"pmid\": \"40747696\", \"title\": \"Effects of maternal allergy and supplementation with ω-3 fatty acid and probiotic on human milk oligosaccharides.\", \"year\": \"2025\"}, {\"pmid\": \"40290019\", \"title\": \"Bifidogenic Effect of 2'-Fucosyllactose (2'-FL) on the Gut Microbiome of Healthy Formula-Fed Infants: A Randomized Clinical Trial.\", \"year\": \"2025\"}, {\"pmid\": \"39408354\", \"title\": \"Effects of Human Milk Oligosaccharide 2'-Fucosyllactose Ingestion on Weight Loss and Markers of Health.\", \"year\": \"2024\"}, {\"pmid\": \"37657523\", \"title\": \"Inulin-type fructans and 2'fucosyllactose alter both microbial composition and appear to alleviate stress-induced mood state in a working population compared to placebo (maltodextrin): the EFFICAD Trial, a randomized, controlled trial.\", \"year\": \"2023\"}, {\"pmid\": \"37511184\", \"title\": \"An Extensively Hydrolyzed Formula Supplemented with Two Human Milk Oligosaccharides Modifies the Fecal Microbiome and Metabolome in Infants with Cow's Milk Protein Allergy.\", \"year\": \"2023\"}, {\"pmid\": \"37242222\", \"title\": \"Infants Fed Breastmilk or 2'-FL Supplemented Formula Have Similar Systemic Levels of Microbiota-Derived Secondary Bile Acids.\", \"year\": \"2023\"}, {\"pmid\": \"36789945\", \"title\": \"The effects of 2'-fucosyllactose and lacto-N-neotetraose, galacto-oligosaccharides, and maternal human milk oligosaccharide profile on iron absorption in Kenyan infants.\", \"year\": \"2023\"}, {\"pmid\": \"35807803\", \"title\": \"Growth and Gastrointestinal Tolerance in Healthy Term Infants Fed Milk-Based Infant Formula Supplemented with Five Human Milk Oligosaccharides (HMOs): A Randomized Multicenter Trial.\", \"year\": \"2022\"}, {\"pmid\": \"35676397\", \"title\": \"Association of human milk oligosaccharides and nutritional status of young infants among Bangladeshi mother-infant dyads.\", \"year\": \"2022\"}, {\"pmid\": \"35276889\", \"title\": \"Effects of an Extensively Hydrolyzed Formula Supplemented with Two Human Milk Oligosaccharides on Growth, Tolerability, Safety and Infection Risk in Infants with Cow's Milk Protein Allergy: A Randomized, Multi-Center Trial.\", \"year\": \"2022\"}, {\"pmid\": \"35193609\", \"title\": \"Safety and efficacy of a probiotic-containing infant formula supplemented with 2'-fucosyllactose: a double-blind randomized controlled trial.\", \"year\": \"2022\"}, {\"pmid\": \"34836092\", \"title\": \"The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel Syndrome.\", \"year\": \"2021\"}, {\"pmid\": \"34445031\", \"title\": \"Clinical Evaluation of 16-Week Supplementation with 5HMO-Mix in Healthy-Term Human Infants to Determine Tolerability, Safety, and Effect on Growth.\", \"year\": \"2021\"}, {\"pmid\": \"34139746\", \"title\": \"Human Milk Oligosaccharides Modulate Fecal Microbiota and Are Safe for Use in Children With Overweight: A Randomized Controlled Trial.\", \"year\": \"2021\"}, {\"pmid\": \"33233658\", \"title\": \"A Partly Fermented Infant Formula with Postbiotics Including 3'-GL, Specific Oligosaccharides, 2'-FL, and Milk Fat Supports Adequate Growth, Is Safe and Well-Tolerated in Healthy Term Infants: A Double-Blind, Randomised, Controlled, Multi-Country Trial.\", \"year\": \"2020\"}, {\"pmid\": \"32536023\", \"title\": \"Human milk oligosaccharide supplementation in irritable bowel syndrome patients: A parallel, randomized, double-blind, placebo-controlled study.\", \"year\": \"2020\"}, {\"pmid\": \"32426882\", \"title\": \"A randomized controlled trial of different young child formulas on upper respiratory and gastrointestinal tract infections in Chinese toddlers.\", \"year\": \"2020\"}, {\"pmid\": \"32401307\", \"title\": \"Human milk oligosaccharides and their association with late-onset neonatal sepsis in Peruvian very-low-birth-weight infants.\", \"year\": \"2020\"}, {\"pmid\": \"32184252\", \"title\": \"Linking Human Milk Oligosaccharides, Infant Fecal Community Types, and Later Risk To Require Antibiotics.\", \"year\": \"2020\"}, {\"pmid\": \"31671757\", \"title\": \"Maternal Human Milk Oligosaccharide Profile Modulates the Impact of an Intervention with Iron and Galacto-Oligosaccharides in Kenyan Infants.\", \"year\": \"2019\"}, {\"pmid\": \"31504099\", \"title\": \"The association of human milk oligosaccharides with glucose metabolism in overweight and obese pregnant women.\", \"year\": \"2019\"}, {\"pmid\": \"31406230\", \"title\": \"Fecal microbiome and metabolome of infants fed bovine MFGM supplemented formula or standard formula with breast-fed infants as reference: a randomized controlled trial.\", \"year\": \"2019\"}, {\"pmid\": \"31248026\", \"title\": \"Confirmed Hypoallergenicity of a Novel Whey-Based Extensively Hydrolyzed Infant Formula Containing Two Human Milk Oligosaccharides.\", \"year\": \"2019\"}, {\"pmid\": \"28794206\", \"title\": \"Lipid-Based Nutrient Supplements During Pregnancy and Lactation Did Not Affect Human Milk Oligosaccharides and Bioactive Proteins in a Randomized Trial.\", \"year\": \"2017\"}, {\"pmid\": \"28726512\", \"title\": \"Human milk oligosaccharide categories define the microbiota composition in human colostrum.\", \"year\": \"2017\"}, {\"pmid\": \"28558732\", \"title\": \"Safety and tolerability of Bifidobacterium longum subspecies infantis EVC001 supplementation in healthy term breastfed infants: a phase I clinical trial.\", \"year\": \"2017\"}, {\"pmid\": \"28107288\", \"title\": \"Effects of Infant Formula With Human Milk Oligosaccharides on Growth and Morbidity: A Randomized Multicenter Trial.\", \"year\": \"2017\"}, {\"pmid\": \"26907090\", \"title\": \"FUT2-dependent breast milk oligosaccharides and allergy at 2 and 5 years of age in infants with high hereditary allergy risk.\", \"year\": \"2017\"}, {\"pmid\": \"27798337\", \"title\": \"Similar to Those Who Are Breastfed, Infants Fed a Formula Containing 2'-Fucosyllactose Have Lower Inflammatory Cytokines in a Randomized Controlled Trial.\", \"year\": \"2016\"}, {\"pmid\": \"27719686\", \"title\": \"Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota.\", \"year\": \"2016\"}, {\"pmid\": \"26154029\", \"title\": \"Infants Fed a Lower Calorie Formula With 2'FL Show Growth and 2'FL Uptake Like Breast-Fed Infants.\", \"year\": \"2015\"}, {\"pmid\": \"24135979\", \"title\": \"Prebiotic oligosaccharides in premature infants.\", \"year\": \"2014\"}, {\"pmid\": \"23993139\", \"title\": \"A comparison of two probiotic strains of bifidobacteria in premature infants.\", \"year\": \"2013\"}, {\"pmid\": \"22894939\", \"title\": \"Human milk oligosaccharide concentration and risk of postnatal transmission of HIV through breastfeeding.\", \"year\": \"2012\"}, {\"pmid\": \"17951479\", \"title\": \"Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life.\", \"year\": \"2007\"}]", "max_studied_dose": "", "minimum_tested_positive_dose": "", "n_participants": "", "n_rct_human": 39, "pmid_ids_json": "[\"17951479\", \"22894939\", \"23993139\", \"24135979\", \"26154029\", \"26907090\", \"27719686\", \"27798337\", \"28107288\", \"28558732\", \"28726512\", \"28794206\", \"31248026\", \"31406230\", \"31504099\", \"31671757\", \"32184252\", \"32401307\", \"32426882\", \"32536023\", \"33233658\", \"34139746\", \"34445031\", \"34836092\", \"35193609\", \"35276889\", \"35676397\", \"35807803\", \"36789945\", \"37242222\", \"37511184\", \"37657523\", \"39408354\", \"40290019\", \"40747696\", \"41243448\", \"41865803\", \"42588060\", \"42635599\"]", "pmid_level": "1", "pmids_loaded": 39, "pubmed_error": "", "pubmed_status": "ok", "query": "(((\"2'-FL\"[ti] OR \"2-fucosyllactose\"[ti] OR \"human milk oligosaccharides\"[tiab]))) AND randomized controlled trial[pt] AND humans[mh] NOT (retracted publication[pt] OR retraction of publication[pt])", "query_valid": true, "rct_count": 39, "records_after_title_year_dedupe": 39, "retracted_count": 0, "retraction_checked_at": "2026-09-15", "retractions_excluded": true, "rob_flag": "", "rows_after_dedupe": 39, "rows_before_dedupe": 39, "sponsor_share": "", "status": "ok", "taxon_in_ncbi": null, "term": "((\"2'-FL\"[ti] OR \"2-fucosyllactose\"[ti] OR \"human milk oligosaccharides\"[tiab]))", "truncated": "0", "zero_phrase": "" }, "form_mix": {}, "form_mix_of": 0, "formula_version": "gis_v1", "generated_at": "2026-09-20T00:00:00Z", "identity_key": null, "identity_peers": [], "label_versions": [ { "brand": "Metagenics", "censored": "1", "diff_flags_json": "{}", "effective_from": "", "effective_to": "", "entry_date": "2020-03-24", "gis": "", "grams_per_serving": null, "grams_per_serving_printed": false, "label_version_id": "216415", "link_confidence": "", "literature_stability_citation": null, "literature_stability_range": null, "observation_kind": "light", "observed": "1", "observed_at": "2020-03-24", "off_market_date": "", "per_strain_cfu": null, "per_strain_quantity": false, "potency_basis": "unstated", "prev_version_id": "", "product": "MetaKids Nutrition Powder Chocolate Flavor", "record_key": "a450bd891c36ddd05eea1a7bfcd298519164bcd2daa2b53792252a873ee662f0", "relationships_json": "[]", "sku_id": "sku:metakids-nutrition-powder-chocolate-flavor", "strain_named": false, "upc": "", "version_count": 1 }, { "brand": "Culturelle Kids", "censored": "1", "diff_flags_json": "{}", "effective_from": "", "effective_to": "", "entry_date": "2022-09-22", "gis": "", "grams_per_serving": null, "grams_per_serving_printed": false, "label_version_id": "273848", "link_confidence": "", "literature_stability_citation": null, "literature_stability_range": null, "observation_kind": "light", "observed": "1", "observed_at": "2022-09-22", "off_market_date": "", "per_strain_cfu": null, "per_strain_quantity": false, "potency_basis": "unstated", "prev_version_id": "", "product": "Grow + Thrive", "record_key": "dcb75d2b0b6448061aad39e5ac4d7a378b1945a5c82d662559ae7e4f3da44d31", "relationships_json": "[]", "sku_id": "sku:grow-thrive", "strain_named": false, "upc": "", "version_count": 1 }, { "brand": "Metagenics", "censored": "1", "diff_flags_json": "{}", "effective_from": "", "effective_to": "", "entry_date": "2023-09-25", "gis": "", "grams_per_serving": null, "grams_per_serving_printed": false, "label_version_id": "295766", "link_confidence": "", "literature_stability_citation": null, "literature_stability_range": null, "observation_kind": "light", "observed": "1", "observed_at": "2023-09-25", "off_market_date": "", "per_strain_cfu": null, "per_strain_quantity": false, "potency_basis": "unstated", "prev_version_id": "", "product": "MetaKids Nutrition Powder Vanilla Flavor", "record_key": "bf6cf46c96458e7a3528fb0a4bab8791e103839024415eaa40986633822b1af2", "relationships_json": "[]", "sku_id": "sku:metakids-nutrition-powder-vanilla-flavor", "strain_named": false, "upc": "", "version_count": 1 } ], "merged_entity_ids": [ "gut_substance:hmo" ], "name": "HMO", "name_variants": [], "on_market_sku_ids": [ "sku:grow-thrive", "sku:metakids-nutrition-powder-chocolate-flavor", "sku:metakids-nutrition-powder-vanilla-flavor" ], "organism_rows": [], "page_id": "s--hmo", "page_type": "entity", "panels": [], "pmid_ids": [ "17951479", "22894939", "23993139", "24135979", "26154029", "26907090", "27719686", "27798337", "28107288", "28558732", "28726512", "28794206", "31248026", "31406230", "31504099", "31671757", "32184252", "32401307", "32426882", "32536023", "33233658", "34139746", "34445031", "34836092", "35193609", "35276889", "35676397", "35807803", "36789945", "37242222", "37511184", "37657523", "39408354", "40290019", "40747696", "41243448", "41865803", "42588060", "42635599" ], "price_per_day_spread": null, "price_per_gram_spread": null, "reformulation_count": 0, "reformulation_products": 0, "reformulations": [], "related_reports": [ { "name": "Strain naming census", "route": "/reports/strain-naming-census/" }, { "name": "Label designation changes", "route": "/reports/label-designation-changes/" }, { "name": "Strain dose match", "route": "/reports/strain-dose-match/" }, { "name": "Stability literature gaps", "route": "/reports/stability-literature-gaps/" } ], "related_tools": [ { "name": "DSLD product check", "route": "/check/" }, { "name": "Unit value calculator", "route": "/calc/" } ], "release": "2026-09-20", "route": "/s/hmo/", "score_scale": 100, "source_sha256": "b7633f732437b71d37c215a03b19abfa8c91d45411579d976d6a926a0140339a", "strains": [], "table_cap": 100, "unresolved_label_ids": [], "unresolved_skus": [], "weights": { "A1": 0.45, "A2": 0.55 } }